本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Scinai Immunotherapeutics Ltd.

1.52
-0.0200-1.30%
盘后1.580.0600+3.95%19:54 EDT
成交量:7.77万
成交额:11.96万
市值:151.99万
市盈率:0.26
高:1.58
开:1.58
低:1.50
收:1.54
52周最高:6.18
52周最低:1.40
股本:99.99万
流通股本:73.47万
量比:0.53
换手率:10.58%
股息:- -
股息率:- -
每股收益(TTM):5.95
每股收益(LYR):5.95
净资产收益率:177.37%
总资产收益率:-34.92%
市净率:0.35
市盈率(LYR):0.26

数据加载中...

2025/05/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/12

SEC问询函

Form CORRESP - Correspondence
2025/03/11

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/03/04

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/20

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/05/15

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/12

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

SEC问询函

Form CORRESP - Correspondence
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/26

SEC问询函

Form CORRESP - Correspondence
2023/12/22

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/08/23

SEC问询函

Form CORRESP - Correspondence
2023/06/08

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

Form 8-K - Current report
2023/05/04

重要事件披露

Form 8-K - Current report
2023/05/04

重要事件披露

Form 8-K - Current report